ANNUAL CONFERENCE OF THE CANADIAN BLOOD AND MARROW TRANSPLANT GROUP. May 13 16, 2015

Transcription

1 May 13 16, 2015 Le Centre Sheraton Hotel, 1201 Boulevard René Lévesque West, Montreal, QC Malachite Management Inc T F mgmt.com Web:

2 Conference Planning Committee Chair: Silvy Lachance, MD, FRCP, CSPQ Committee members: Imran Ahmad, MD Gizelle Popradi, MD, FRCPC Marie France Vachon, RN, MScN, CPON, CON(C), CHTC Stephen Couban, MD, FRCPC Matthew Seftel, MD, MPH, MRCP, FRCPC Lisa Martin, MLT Registration Pierre Teira, MD Registration will open on January 12, 2015 The early bird registration deadline is April 1, 2015 Full Conference Registration: Early Bird Registration Fee Regular Registration Fee Physician/PhD Member $382 + tax $432 + tax Allied Health Member $250 + tax $300 + tax In-Training/Fellow Member $200 + tax $250 + tax Non-CBMTG member $475 + tax $525 + tax One Day Conference Registration: Early Bird Registration Fee Regular Registration Fee Physician/PhD Member $157 + tax $182 + tax Allied Health Member $125 + tax $150 + tax In-Training/Fellow Member $100 + tax $125 + tax Non-CBMTG member $200 + tax $225 + tax Abstract Submission Abstracts will be accepted from Janaury 5, 2015 to February 27, 2015 CBMTG members and non members from all BMT related disciplines are encouraged to submit abstract(s) for presentation at the annual conference. Abstracts may address evaluative studies, research in progress or descriptive reports, and are invited on a broad range of BMT related topics, including basic, translational and/or clinical research and issues in clinical practice, including but not limited to team development, education, psychosocial issues and novel care delivery approaches. Abstracts are accepted in the following categories: Research: basic/translational Clinical: clinical trials/observations Clinical: laboratory/quality Clinical: pharmacy, nursing, other transplant support 2 T: F: E: cbmtg@malachite-mgmt.com W:

3 DAY 1 THURSDAY, MAY 14, :00am 10:00am 10:15am 11:45am 12:00pm 1:30pm 1:45pm 2:45pm 2:45pm 3:00pm Symposium 1: Breakfast Session 1: Canadian Blood and Marrow Transplant Group (CBMTG) Canadian National Transplant Research Program (CNTRP) Joint Session Renal and Hematopoietic Cell Transplant for Tolerance Induction Stephan Busque, MD, MSc, FRCSC Session 2: Graft-Versus-Host Disease HANS MESSNER LECTURESHIP: NIH Consensus on Chronic GVHD at 10 Years: Looking Back and Looking Forward Paul Martin, MD ECP Canadian Experience David Barth, MD Symposium 2: Lunch Session 3: Transplant from the Donor Perpective Donor Selection and Safety Bronwen Shaw, MD 3:00pm 4:30pm Session 4A: BMT 101 How to Select Conditioning Regimen for Allogeneic SCT Chris Bredeson, MD, MSc, FRCPC Updates in CMV Donald Vinh, MD Autologous Conditioning Regimens for Lymphoma: Moving Away from BCNU Philippe Bouchard, MSc, BCOP Session 4B: Nursing Myeloblative and Reduced Intensity Conditioning Regimen: Nursing Perspective Marie-France Vachon, RN, MScN, CPON, CON(C), CHTC The Impact of Loss on the Transplant Team Sylvie Fortin, PhD Transitioning from a Pediatric Transplant Centre to an Adult Transplant Centre: What Patients Have to Say! TBD Session 4C: Laboratory Technologists New HLA Typing Technologies Marie Christine Meunier, PhD Experiences Changing from Pentaspan to a New Crypreservation Method Heidi Elmoazzen, PhD, Lisa Martin, MLT, CQE, Mike Halpenny, MLT (CMLTD) 4:45pm 5:45pm 5:45pm 6:45pm 7:00pm 9:00pm Session 5: Oral Abstract Presentations Welcome Reception CBMTG Town Hall Dinner will be provided 3 T: F: E: cbmtg@malachite-mgmt.com W:

4 DAY 2 FRIDAY, MAY 15, 2015 Symposium 4: Breakfast 9:00am 10:00am Session 6: Canadian Blood and Marrow Transplant Group (CBMTG) International Society for Cellular Therapy (ISCT) Joint Session Understanding Stem Cells Aging as a Platform to Enhance Tissue Regeneration Massimo Dominci, MD, ISCT President 10:15am 11:15pm 11:30am 1:00pm 1:15pm 3:15pm 3:15pm 3:30pm 3:30pm 5:00pm 5:00pm 6:00pm 7:00pm Onwards Annual General Meeting Symposium 5: Lunch Session 7: Myelodysplastic Syndrome Debate: MDS should be treated prior transplant For the resolution: Rena Buckstein, MD, FRCPC Against the resolution: Thomas Nevill, MD, FRCPC How to Optimize Allogeneic Hematopoietic Cell Transplant for High Risk Patients with MDS Corey Cutler, MD, MPH Clinical Trials Network and BMT Registry Meeting Session 8: Fred Saunders Lectureship CARS State of the Art and Potential Role in HSCT Stephan Grupp, MD, PhD Social Event DAY 3 SATURDAY, MAY 16, :00am 12:00pm Symposium 6: Breakfast Session 9: Cord Blood Cord Blood Stem Cell Expansion Peter Zandstra, PhD, FRSC, Guy Sauvageau, MD, PhD, FRCPC : The Canadian Experience in Cord Blood Transplantation Michel Duval, MD Challenges Facing Cord Blood Transplant in 2015 Vanderson Rocha, MD, PhD 12:15pm 1:45pm 2:00pm 3:00pm 3:00pm 3:30pm 3:30pm 5:00pm Symposium 7: Lunch Session 10: Till and McCulloch Lectureship The Importance of Thymic Function in Allogeneic SCT Marcel van den Brink, MD, PhD Closing remarks Héma Québec Wet Lab 4 T: F: E: cbmtg@malachite-mgmt.com W:

5 Board of Directors President, Christopher Bredeson, MD, MSc, FRCPC Past President, Silvy Lachance, MD, FRCPC, CSPQ President-Elect, Andrew Daly, MDCM, FRCPC Treasurer, Raewyn Broady, MBChB, FRACP, FRCPA, FRCPC Secretary, Jennifer Wiernikowski, MN, NP-Adult, CON(C) Director-at-large, Research Donna Wall, MD Director-at-large, Education Naheed Alam, MD About CBMTG The Canadian Blood and Marrow Transplant Group (CBMTG) is a national, voluntary, and multi-disciplinary organization providing leadership and promoting excellence in patient care, research, and education in the field of BMT. CBMTG s vision is that Canada will be the best place in the world to have a blood and marrow transplant. Furthermore, the mission of the association is that the Canadian Blood and Marrow Transplant Group is the voice of experts working in the field of blood and marrow transplant. The CBMTG s values are: excellence, innovation, integrity, collaboration and professionalism in care, education and research in blood and marrow transplant. While the association s philosophy is: CBMTG believes that every patient has a right of equal access to the highest quality of life saving care that can be provided by blood and marrow transplant professionals in Canada. Based on this, our strategic priorities are as follows: Education Providing high quality educational programs that advance the practice of blood and marrow transplantation in Canada. Research Establish and organize an effective and sustainable research infrastructure for translational and clinical research. Outreach Increase the visibility and influence of CBMTG among members and the public. Financial Capacity To support, education, research and outreach initiatives through fundraising, partnerships and the establishment of a charitable organization. CBMTG Membership: The CBMTG membership is made up of national and international physicians, nurses, laboratory technicians, pharmacists, and coordinators working in blood and marrow transplant. FOR MORE INFORMATION, PLEASE VISIT 5 T: F: E: cbmtg@malachite-mgmt.com W: